Skip to content

Smartphone APP for Real-Time Blood Pressure Monitor and Control Trial

Smartphone APP for Real-Time Blood Pressure Monitor and Control Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017829
Enrollment
Unknown
Registered
2018-08-16
Start date
2018-08-20
Completion date
Unknown
Last updated
2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Group 1:It is required to follow up every two months for outpatient visits, and the APP collects blood pressure without interaction.
Group 2:Self-test blood pressure at home is required to be at least 2 times a day (including at least one in the morning and evening)
patients are encouraged to conduct interactive communication feedback, and the doctor actively monitors and intervenes at least 2 times a week
reminds each time of medication

Sponsors

The General Hospital of the People's Liberation Army (Hainan)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. >60 years old; 2. The systolic blood pressure measured in two clinics on different days is greater than or equal to 140mmHg; 3. Self-reported use of less than 1-2 antihypertensive drugs, such as thiazide diuretics, CCB, beta-blockers, ACE-I, ARB, etc., and confirmed by researchers; 4. The blood pressure is less than or equal to 180/120mmHg in the outpatient clinic; 5. Ability to improve baseline information; 6. Voluntarily participate in and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. <60 years old; 2. Two systolic blood pressures measured <140mmHg; 3. Currently participating in other blood pressure control studies or smartphone APP related research; 4. Unable to use iOS or Android system smartphones; 5. Currently more than 2 antihypertensive drugs are used; 6. Chemotherapy or radiation therapy is currently underway; 7. Can't understand Chinese; 8. bilateral renal artery stenosis; 9. There is no guarantee of returning after 2 years; 10. The arm circumference is too large or too small for the research sleeve; 11. Currently receiving dialysis treatment; 12. It is not possible to collect complete baseline data; 13. The presence of a disease that may result in a survival time of less than 3 years, or a tumor diagnosed and treated within the past two years, may result in the patient not being able to cope well with the research process; 14. Inability to obtain informed consent; 15. There are obvious other abnormal signs, laboratory tests and clinical diseases, which are not suitable for researchers according to the judgment of the researchers.

Design outcomes

Primary

MeasureTime frame
hypertension;Type and quantity of medication;Cardiac Function;Renal function;

Secondary

MeasureTime frame
Morisky 8-item medication adherence scale;GPAQ scale;SF-12 sclae;Diet self-report;Consumer Health Activation Index;

Countries

China

Contacts

Public ContactMingzhi Shen

The General Hospital of the People's Liberation Army (Hainan)

shenmingzhi1981@163.com+86 15692538276

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026